Clinical & Radiographic Evaluation of LSTR in Non-vital Primary Molars Using Two Different Vehicles (LSTR)

Clinical and Radiographic Evaluation of Lesion Sterilization and Tissue Repair in Non-vital Primary Molars Using Double Antibiotic Paste With Two Different Vehicles (Randomized Clinical Trial and In Vitro Study)

LSTR will be done for primary teeth with significant root resorption needing non-vital pulp therapy to save such teeth for up to 12 months. The first part will be in vitro study to compare the antimicrobial effect of double antibiotic paste mixed with chitosan nanoparticle vs double antibiotic paste mixed with propylene glycol. The second part will be randomized clinical trial comparing the clinical and radiographic success of LSTR in study group where double antibiotic mix is mixed with chitosan nanoparticles and control group where double antibiotic paste is mixed with propylene glycol .

Study Overview

• Status: Not yet recruiting
• Conditions: Resorption of Tooth or Root
• Intervention / Treatment: Drug: Double antibiotic paste mixed with chitosan nanoparticles; Drug: Double antibiotic paste mixed with propylene glycol

Detailed Description

Clinical and Radiographic Evaluation of Lesion Sterilization and Tissue Repair in Non-vital Primary Molars Using Double Antibiotic Paste with Two Different Vehicles (Randomized Clinical Trial and In Vitro Study)

Introduction:

Healthy primary teeth are important for speech, mastication and to maintain the space for their permanent successors developing in the jaw underneath. Teeth with infected root canals, particularly those in which the infection has reached the peri-radicular tissues, are a common problem in the primary dentition. A relatively new biologic approach, lesion sterilization and tissue repair therapy (LSTR) was introduced. It was modified from 3 mix 1:1:1 metronidazole, ciprofloxacin and minocycline to double mix where 1:1 metronidazole and ciprofloxacin are mixed with propylene glycol. It is indicated for primary teeth with significant root resorption (external resorption greater than 1 mm and/ or internal resorption) needing non-vital pulp therapy. It is also indicated when the clinician decides not to extract the tooth with significant preoperative root resorption, LSTR should be the choice over pulpectomy to save such teeth for up to 12 months. Chitosan it is a natural nontoxic, biocompatible, biodegradable polysaccharide with broad antibacterial spectrum (covering gram-negative and gram-positive bacteria as well as fungi), and it has antioxidant and antitumor properties, also it has the ability to form film and gel. Chitosan and chitosan nanoparticle can be used as a vehicle for incorporating natural or chemical antimicrobial agents, however, chitosan nanoparticles exhibit a higher antimicrobial activity than chitosan. Also, chitosan nanoparticles have better absorption and penetration into dentinal tubules

Aim of Study:

1. To evaluate the clinical and radiographic outcomes of using double antibiotic paste mixed with chitosan nanoparticles gel vs. double antibiotic paste mixed with propylene glycol in lesion sterilization and tissue repair in non-vital primary molars.
2. Both materials will be compared in terms of ease of handling, time to perform procedure and convenience of application.
3. Comparing the antibacterial effect of double antibiotic paste mixed with chitosan nanoparticles gel vs. that mixed with propylene glycol in vitro.

Methodology:

1. In Vitro Microbiological Study Before the initiation of the clinical trial, an in vitro study will be carried out. A pilot study to assess the antimicrobial effect of double antibiotic paste mixed with a vehicle of chitosan nanoparticles gel of 2 different concentrations (0.3% and 0.5%) in order to determine which is the better concentration to be used in the lesion sterilization and tissue repair.

   A microbiological study will be carried out to compare the antimicrobial effect of double antibiotic paste mixed with the better concentration of chitosan nanoparticles gel according to the pilot study and double antibiotic paste mixed with propylene glycol. Sample size n=14, each group n=7.

   Procedures:

   A swab will be taken from non-vital primary molars with a paper point and it will be inserted in a suitable transporting medium and cultivated in a suitable medium and different bacterial strains will be identified. The strains will then be isolated and cultivated in suitable media. Materials under investigation will be added to identify the inhibition zones diameters.

2. In Vivo Study

A randomized controlled trial, with 1:1 allocation ratio to either study group (group 1) or control group (group 2). Participants will be medically free children, in the age group 4-7 years, having non-vital primary molars with root resorption more than 1 mm that needs to be retained a tooth for up to 12 months that otherwise would be extracted. Sample size: n=36 molars, (group1) n=18 molars where LSTR will be performed with double antibiotic paste mixed with chitosan nanoparticles gel and (group 2) n=18 molars here LSTR will be performed with double antibiotic paste mixed with propylene glycol.

Procedures:

Caries will be removed with a sterile large round high-speed then pulpotomy will be performed and coronal pulp tissue will be removed using a sterile small sharp excavator, followed by irrigation with 1% sodium hypochlorite. Dryness will be done then double antibiotic will be mixed with chitosan nanoparticles gel until a creamy mix is formed then the mix will be placed in the pulp chamber for (group 1), while double antibiotic will be mixed with propylene glycol until a creamy mix is formed, then the mix will be placed in the pulp chamber for the (group 2). The glass ionomer will be injected to fill the pulp chamber and finally the tooth will be restored with a stainless-steel crown. Follow up will be for one year with recall visits at 1, 3, 6 and 12 months.

Clinical outcome: Reduction/absence of pain, no abnormal mobility/ swelling or abscess.

Radiographic outcomes: Decrease or resolution in interradicular radiolucency and decrease/absence of internal resorption.

• Study Type: Interventional
• Enrollment (Anticipated): 36
• Phase: Phase 3

Contacts and Locations

• Study Contact: Name: Dina AH Ghaneya, MS; Phone Number: 002 01006263615; Email: dina.abdelhaleem88@gmail.com
• Study Contact Backup: Name: Radwa AE El Shakhs, MS; Phone Number: 022 01223183320; Email: drradwaelshakhs@hotmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 4 years to 7 years (Child)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

1-Non-vital primary molars

1. With root resorption more than 1 mm that needs to be retained a tooth for up to 12 months that otherwise would be extracted
2. Without mobility up to grade I mobility.

Exclusion Criteria:

1. Non-vital primary molars

   1. With perforation into the bifurcation.
   2. Badly broken down.
   3. With no root resorption.
   4. With excessive bone loss in furcation area involving underlying tooth germ.
   5. Nearing exfoliation.

2. Participants that

   1. Have previous history of allergy to the antibiotics used in the study.
   2. Their caregivers do not oblige to signing the informed consent.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Group 1; study group	Drug: Double antibiotic paste mixed with chitosan nanoparticles; Lesion sterilization and tissue repair in non-vital primary molars with double antibiotic paste mixed with chitosan nanoparticles gel; Other Names: DAP mixed with CHNPs
Other: Group 2; control group	Drug: Double antibiotic paste mixed with propylene glycol; Lesion sterilization and tissue repair in non-vital primary molars with double antibiotic paste mixed with propylene glycol; Other Names: DAP mixed with PG

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Clinical outcomes through clinical examination	No pain. No abnormal mobility. No swelling	Follow up will be for one year with recall visits at 1, 3, 6 and 12 months
Radiographic outcomes by comparing pre and post treatment radiographic pathologic radiolucent area/s size/s	Decrease in size / absence of interradicular radiolucency. Decrease in size /absence of internal resorption.	Follow up will be for one year with recall visits at 1, 3, 6 and 12 months

Collaborators and Investigators

• Sponsor: Ain Shams University
• Investigators: Study Chair: Olaa Abdel Geleel, PhD, Ain Shams University

Study record dates

Study Major Dates

• Study Start (Anticipated): December 1, 2021
• Primary Completion (Anticipated): December 31, 2023
• Study Completion (Anticipated): March 31, 2024

Study Registration Dates

• First Submitted: October 3, 2021
• First Submitted That Met QC Criteria: October 3, 2021
• First Posted (Actual): October 15, 2021

Study Record Updates

• Last Update Posted (Actual): November 8, 2021
• Last Update Submitted That Met QC Criteria: October 30, 2021
• Last Verified: October 1, 2021

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Molecular Mechanisms of Pharmacological Action; Anti-Infective Agents; Antimetabolites; Anticholesteremic Agents; Hypolipidemic Agents; Lipid Regulating Agents; Hemostatics; Coagulants; Antitubercular Agents; Chelating Agents; Sequestering Agents; Anti-Bacterial Agents; Antibiotics, Antitubercular; Chitosan
• Other Study ID Numbers: PED21-7D

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No